INTRODUCTION 70
Animals are used as preclinical model for human diseases in drug development. While 71 central to drug development, there is lack of validity for many of such tests. 72 Evidential weight gain accrued by the use of animal data was assessed in a recent study, 73 evaluating the probability that a certain new tested drug may prove toxic to humans 1 . The authors 74 calculated likelihood ratios (LR) for a large set of drugs. They have shown that lack of toxicity in 75 fact provides no weight gain for lack of adverse drug reactions, as well as large inconsistencies 76 in LR when predicting from animals to human 1 . We have incorporated several datasets in the analysis to have a broader view upon the 102 potential differences in and between the two species as across breeds, across human Wellderly present a well-being well aged cohort of mixed ethnicity. The Alzheimer's cohort is a 109 mixed ethnicity cohort offering yet another point of comparison. Using the same settings across 110 datasets we calculated ROH across different dog breeds (EMBARK project) with emphasis on 111 the beagle, as it is the preferred breed in drug development. We evaluate the degree of inbreeding 112 in dogs compared to human populations. We furthermore focus on the CYP family, as they are 113 the major class of enzymes involved in drug metabolism, accounting for 75% of the total 114 metabolism 13 . The results should allow one to investigate the genetic validity of dogs as 115 preclinical models for human drug development. 
RESULTS

118
A ROH is defined as a continuous stretch of DNA sequence without heterozygosity in the 119 diploid state (min ROH = established usually between 500kb and 1.5 Mb).We estimate ROH 120 using PLINK 14 . The hypothesis is that that deleterious genotypes will be enriched in the ROH data. When we considered both the location and the allelic form of the ROHs, we were able to 133 separate the populations by PCA, demonstrating that ROHs contain information on the 134 demographic history and structure of a population. We calculated the extent of the genome 135 covered by ROH (F ROH ) (human 3.2Gb, dog 2.5Gb) as displayed in Table 1. 136 In the Amish population, one of the most inbred human populations, the F ROH was 12x Currently, we classify 298 genes that encode Phase I and II drug metabolizing enzymes, 160 transporters, and modifiers as ADME genes, with CYPs constituting a major family. To further 161 evaluate the consequences we focused on CYP family including most common CYPs involved in 162 metabolism of human drugs including CYP2D6, CYP2B's, CYP2C's, CYP3A's. We mapped 163 orthologues between dogs and human using BIOMART 15 (orthologues, from human to dogs). 164 We report that beagles alone, F_ROH, would be 25% so even higher than our average in beagles, We compared the degree of genetic inbreeding in beagle dogs using the measure of runs of 189 homozygosity (ROH). This therefore focus on contiguous regions of the genome that are 190 inherited as identical from both parents. The study showed that unrelated humans show these 191 regions of homozygosity in about 1/1000 of their genomes while beagle dogs do so in 12.8 192 percent of their genome. In other words beagle dogs are on average 100 times more inbred than 193 humans. In the same study researchers examined the degree of inbreeding in the genetic isolate 194 of the Amish in Pennsylvania which showed that they were about 12 times more inbred than the 195 general population. It is well accepted that drug efficacy and safety studies in genetic isolates 196 such as the Amish cannot be generalized for the population at large.
197
The ADME genes constitutes a highly polymorphic set of genes involved in Absorption, severe adverse reactions to as well as altered potentially efficacy of a wide variety of drugs 21 .
208
Beagle dogs are routinely used for studying the safety of new pharmaceuticals. This practice has 209 been in place for a hundred years and followed by pharmaceutical developers and regulators.
210
The present study is significant in that it casts a big question over the predictive validity of these 211 commonly conducted dog studies. The very high degree of inbreeding seen would suggest that 212 beagle dogs would be a poor model to predict toxicity even for other dog breeds and of course an 
